{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:17:24Z","timestamp":1772803044397,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejphar.2014.03.024","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T02:33:22Z","timestamp":1399689202000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Monoamine reuptake site occupancy of sibutramine: Relationship to antidepressant-like and thermogenic effects in rats"],"prefix":"10.1016","volume":"737","author":[{"given":"Yu-Wen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Langdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Pieschl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Strong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Rohrbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snjezana","family":"Lelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.03.024_bib1","first-page":"345","article-title":"A pilot study to evaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions","volume":"7","author":"Abolfathi","year":"2004","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2014.03.024_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157015912799362788","article-title":"Sibutramine effects on central mechanisms regulating energy homeostasis","volume":"10","author":"Ara\u00fajo","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpba.2009.04.024","article-title":"Analysis of enantiomers of sibutramine and its metabolites in rat plasma by liquid chromatography\u2013mass spectrometry using a chiral stationary-phase column","volume":"50","author":"Bae","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2014.03.024_bib5","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0028-3908(00)00083-6","article-title":"Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid","volume":"39","author":"Balcioglu","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1139\/Y09-080","article-title":"Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats","volume":"87","author":"Chudasama","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","article-title":"Thermogenic effects of sibutramine and its metabolites","volume":"126","author":"Connoley","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib13","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.ijo.0802216","article-title":"Sibutramine: its mode of action and efficacy","volume":"26","author":"Finer","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ejphar.2014.03.024_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00216-8","article-title":"Enantioselective behavioral effects of sibutramine metabolites","volume":"397","author":"Glick","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pbb.2006.03.014","article-title":"Locomotion is the major determinant of sibutramine-induced increase in energy expenditure","volume":"83","author":"Golozoubova","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.03.024_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2010.06.017","article-title":"Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo","volume":"68","author":"Hannestad","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.03.024_bib18","first-page":"S18","article-title":"Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine","volume":"22","author":"Heal","year":"1998","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ejphar.2014.03.024_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00213-010-2106-2","article-title":"Reversal of sibutramine-induced anorexia with a selective 5-HT2C receptor antagonist","volume":"214","author":"Higgs","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2004.05.026","article-title":"Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies","volume":"28","author":"Invernizzi","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.03.024_bib21","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s002130100790","article-title":"Drug-induced receptor occupancy: substantial differences in measurements made in vivo vs ex vivo","volume":"157","author":"Kapur","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2014.03.024_bib23","first-page":"P397","article-title":"Sibutramine: weight loss in depressed patients","volume":"19","author":"Kelly","year":"1995","journal-title":"Int. J. Obesity"},{"key":"10.1016\/j.ejphar.2014.03.024_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-002-1218-8","article-title":"Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652","volume":"164","author":"Kent","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2014.03.024_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2008.04.014","article-title":"ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: methodology and biological significance","volume":"55","author":"Lengyel","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2006.03.020","article-title":"Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors","volume":"51","author":"Li","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(02)02226-4","article-title":"Comparison of the thermogenic and hypophagic effects of sibutramine\u2019s metabolite 2 and other monoamine reuptake inhibitors","volume":"452","author":"Liu","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.ijo.0802062","article-title":"Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine","volume":"26","author":"Liu","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ejphar.2014.03.024_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(02)01423-1","article-title":"The discovery and status of sibutramine as an anti-obesity drug","volume":"440","author":"Luque","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02244604","article-title":"Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl","volume":"100","author":"Luscombe","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib31","first-page":"86","article-title":"Imaging the serotonin transporter during major depressive disorder and antidepressant treatment","volume":"32","author":"Meyer","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ejphar.2014.03.024_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00213-002-1166-3","article-title":"Bupropion occupancy of the dopamine transporter is low during clinical treatment","volume":"163","author":"Meyer","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2014.03.024_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Moron","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.03.024_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00221-003-1582-6","article-title":"Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats","volume":"153","author":"Munoz","year":"2003","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ejphar.2014.03.024_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03033262","article-title":"Effects of sibutramine on the central dopaminergic system in rodents","volume":"3","author":"Nakagawa","year":"2001","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2014.03.024_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1467-789x.2000.00020.x","article-title":"An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action","volume":"1","author":"Nisoli","year":"2000","journal-title":"Obesity Rev."},{"key":"10.1016\/j.ejphar.2014.03.024_bib38","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jamapsychiatry.2013.399","article-title":"Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus","volume":"70","author":"Pietrzak","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ejphar.2014.03.024_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2005.01.034","article-title":"Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents","volume":"511","author":"Rohrbach","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.03.024_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W","article-title":"Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats","volume":"38","author":"Rowley","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2014.03.024_bib42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpsyc.60.4.386","article-title":"High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography","volume":"60","author":"Suhara","year":"2003","journal-title":"Arch. General Psychiatry"},{"key":"10.1016\/j.ejphar.2014.03.024_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-005-0304-0","article-title":"A dose-finding study of duloxetine based on serotonin transporter occupancy","volume":"185","author":"Takano","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2014.03.024_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/npp.2009.182","article-title":"Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans","volume":"35","author":"Talbot","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.03.024_bib45","first-page":"251","article-title":"The neuropharmacology of the autoinhibition of monoamine release","volume":"6","author":"Tepper","year":"1985","journal-title":"TIPs"},{"key":"10.1016\/j.ejphar.2014.03.024_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/oby.2008.550","article-title":"5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats","volume":"17","author":"Thomas","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2014.03.024_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-4159.2005.03030.x","article-title":"Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation","volume":"93","author":"Valentini","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.03.024_bib48","first-page":"131","article-title":"Pharmacotherapies for overeating and obesity","volume":"4","author":"Yarnell","year":"2013","journal-title":"J. Genet. Syndr. Gene Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914002301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914002301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T06:36:19Z","timestamp":1565418979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914002301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":41,"alternative-id":["S0014299914002301"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.03.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoamine reuptake site occupancy of sibutramine: Relationship to antidepressant-like and thermogenic effects in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}